TWINSTRAND BIOSCIENCES INC.

In News

TwinStrand Biosciences and Exact Sciences Announce Exclusive License Agreement for Duplex Sequencing Technology - PR Newswire

PR Newswire - Jul 31, 2024

Guardant Health hit with $83M verdict in TwinStrand DNA sequencing patent lawsuit - Fierce Biotech

Fierce Biotech - Nov 15, 2023

TwinStrand Biosciences Initiates Regulatory Approval Process for Duplex Sequencing Mutagenesis Assays with OECD - PR Newswire

PR Newswire - Apr 24, 2024

Duplex Sequencing Technology Detects Early Carcinogen-Caused Mutagenesis - AJMC

AJMC - Dec 18, 2020

Seattle top biotechs 2025: the 9 companies you should now about - Labiotech.eu

Labiotech.eu - Nov 11, 2025

What MRD in AML Partners Are Saying - FNIH

FNIH - Jun 10, 2023

Guardant Health owes $83.4 mln in DNA sequencing patent case, US jury says - Reuters

Reuters - Nov 15, 2023

Former Fred Hutch president joins board of TwinStrand Biosciences - The Business Journals

The Business Journals - Jan 08, 2021

Federal Jury Finds Guardant Health Willfully Infringes University of Washington Duplex Sequencing Patents Exclusively Licensed to TwinStrand Biosciences, Inc., Awards $83.4M in Damages; PTAB Rejects Invalidity Arguments on UW Patents - PR Newswire

PR Newswire - Nov 15, 2023

Biomarkers Consortium – Measurable residual disease in acute myeloid leukemia (MRD in AML) - FNIH

FNIH - Jun 06, 2023

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment